Medtide Inc. (HKG:3880)
Hong Kong · Delayed Price · Currency is HKD 23.34
-0.10 (-0.43%)
Aug 21, 2026, 3:59 PM HKT
Medtide Market Cap
Medtide has a market cap or net worth of 3.31 billion as of August 21, 2026. Its market cap has decreased by -36.68% in one year.
Market Cap
3.31B
Enterprise Value
2.15B
Revenue
634.40M
Ranking
n/a
PE Ratio
12.88
Stock Price
23.34
ChartMarket Cap Chart
Since June 30, 2025, Medtide's market cap has decreased from 4.37B to 3.31B, a decrease of -24.22%. That is a compound annual growth rate of -21.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 3.31B | -23.43% |
| Dec 31, 2025 | 4.32B | -1.04% |
| Jun 30, 2025 | 4.37B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jacobio Pharmaceuticals Group | 4.12B |
| Qyuns Therapeutics | 3.79B |
| Mirxes Holding Company | 3.66B |
| Viva Biotech Holdings | 3.30B |
| BioDlink International Company | 3.11B |
| Jiangsu Recbio Technology | 3.08B |
| Clover Biopharmaceuticals | 3.08B |
| HJ Science | 3.02B |